Inventor · disambiguated record
Daniel Yohannes
Also filed as: YOHANNES DANIEL
16 granted patents·18 pending applications·157 citations·filing 1997–2019
92Inventor score
Files withTARGACEPT INC8UNIV WAKE FOREST HEALTH SCIENCES5PFIZER4AKIREDDY SRINIVASA RAO3CATALYST BIOSCIENCES INC3
Top patents by PatentIndex Score
34 records- 0191US6949562B2Heterocyclic compounds as ligands of the GABAA receptorPFIZER·Filed 2003·Granted Sep 27, 2005·54 cites·34 claims
- 0291US6653471B2Heterocyclic compounds as ligands of the GABAA receptorNEUROGEN CORP·Filed 2001·Granted Nov 25, 2003·54 cites·27 claims
- 0385US6911477B2Muscarinic receptor agonistsPFIZER·Filed 2003·Granted Jun 28, 2005·19 cites·2 claims
- 0483US10258582B2Nicotinic receptor non-competitive antagonistsCATALYST BIOSCIENCES INC·Filed 2018·Granted Apr 16, 2019·2 cites·3 claims
- 0583US8809397B2Nicotinic receptor non-competitive antagonistsAKIREDDY SRINIVASA RAO·Filed 2011·Granted Aug 19, 2014·5 cites·10 claims
- 0680US9532974B2Nicotinic receptor non-competitive antagonistsTARGACEPT INC·Filed 2015·Granted Jan 3, 2017·2 cites·2 claims
- 0779US8901151B2Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamideTARGACEPT INC·Filed 2013·Granted Dec 2, 2014·3 cites·1 claims
- 0877US8476296B2Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamideBENCHERIF MEROUANE·Filed 2010·Granted Jul 2, 2013·4 cites·15 claims
- 0972US10716770B2Nicotinic receptor non-competitive antagonistsCATALYST BIOSCIENCES INC·Filed 2019·Granted Jul 21, 2020·0 cites·5 claims
- 1072US8633227B2Synthesis and novel salt forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridineAKIREDDY SRINIVASA RAO·Filed 2009·Granted Jan 21, 2014·1 cites·2 claims
- 1171US9173876B2Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamideTARGACEPT INC·Filed 2014·Granted Nov 3, 2015·1 cites·1 claims
- 1267US6861529B2Cycloalkypyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivativesPFIZER·Filed 2002·Granted Mar 1, 2005·3 cites·31 claims
- 1364US2014315877A1Nicotinic receptor non-competitive antagonistsTARGACEPT INC·Filed 2014·Application pending·0 cites
- 1459US2017071878A1Nicotinic receptor non-competitive antagonistsCATALYST BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 1558US2019382336A1HYPDH Inhibitors and Methods of Use for the Treatment of Kidney StonesUNIV WAKE FOREST HEALTH SCIENCES·Filed 2019·Application pending·0 cites
- 1655US7816356B2Aryl and heteroaryltetrahydrocyclobutapyrroles as nicotinic acetylcholine receptor ligandsYOHANNES DANIEL·Filed 2004·Granted Oct 19, 2010·0 cites·1 claims
- 1754US2014107163A1Synthesis and novel salt forms of (r)-3-((e)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridineTARGECEPT INC·Filed 2013·Application pending·0 cites
- 1851US2003236405A17-hetero-bicyclo[2.2.1]-heptanesFiled 2003·Application pending·0 cites
- 1951US2011263629A1Amides of diazabicyclooctanes and uses thereofTARGACEPT INC·Filed 2009·Application pending·0 cites
- 2049US2011257168A1Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligandsTARGACEPT INC·Filed 2009·Application pending·0 cites
- 2148US2002038028A17-Hetero-bicyclo[2.2.1]-heptanesFiled 2001·Application pending·0 cites
- 2248US2002035262A17-hetero-bicyclo[2.2.1]-heptanesFiled 2001·Application pending·0 cites
- 2347US10562844B2HYPDH inhibitors and methods of use for the treatment of kidney stonesUNIV WAKE FOREST HEALTH SCIENCES·Filed 2016·Granted Feb 18, 2020·0 cites·18 claims
- 2447US2017119746A1Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamideATTENUA INC·Filed 2015·Application pending·0 cites
- 2546US6093733AMuscarinic receptor agonistsFiled 1997·Granted Jul 25, 2000·9 cites·20 claims
- 2643US2009093512A11, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta[a]inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulating cholinergic function and in the treatment of addictive disordersPFIZER·Filed 2005·Application pending·0 cites
- 2741US2015031675A1Diazabicyclo[3.3.1]nonanes, methods of synthesis, and uses thereofTARGACEPT INC·Filed 2013·Application pending·0 cites
- 2841US2014288185A1Nicotinic receptor non-competitive modulatorsTARGACEPT INC·Filed 2012·Application pending·0 cites
- 2939US2002103194A1Novel muscarinic receptor agonistsFiled 2000·Application pending·0 cites
- 3037US10829519B2Angiotensin (1-7) analogs and methods relating theretoUNIV WAKE FOREST HEALTH SCIENCES·Filed 2016·Granted Nov 10, 2020·0 cites·30 claims
- 3137US2014288169A1Nicotinic receptor non-competitive antagonistsAKIREDDY SRINIVASA RAO·Filed 2012·Application pending·0 cites
- 3236US2020261419A1Combinations for the treatment of kidney stonesUNIV WAKE FOREST HEALTH SCIENCES·Filed 2016·Application pending·0 cites
- 3333US2012053168A1Fused benzoazepines as neuronal nicotinic acetylcholine receptor ligandsBHATTI BALWINDER SINGH·Filed 2010·Application pending·0 cites
- 3430US2020262794A1Glycolate oxidase inhibitors and methods of use for the treatment of kidney stonesUNIV WAKE FOREST HEALTH SCIENCES·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Yohannes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →